![](https://staging.lms.physiciansweekly.com/wp-content/uploads/2024/07/028.png)
Stereotactic Ablative Radiotherapy Safe for Unresectable NSCLC With ILD
This course discusses the safety of stereotactic ablative radiotherapy in patients with early non-small cell lung cancer and interstitial lung disease.
Click CE Information to start the course. Post Test and Evaluation must be completed to earn certificate of completion.